Skip to main content

Abstract

Alexander disease (AxD) is an autosomal dominant or sporadically inherited astrogliopathy caused by mutations in an intermediate filament protein, glial fibrillary acidic protein (encoded by GFAP). Individuals may present with an infantile-onset leukoencephalopathy and seizures, with significant basal ganglia involvement, and with contrast enhancement on MRI (Type I). In some cases the initial presentation can be of febrile status, which with the MRI features could be confused with acute disseminated encephalomyelitis (ADEM). Individuals may also present in older childhood, adolescence, or adulthood, often with a predominant posterior fossa or brainstem presentation (Type II). When brainstem contrast enhancement is seen, this disorder could be confused with multiple sclerosis or a brainstem glioma. In this chapter, two cases of typical presentation of Type II AxD are described followed by a discussion of the genetics, pathophysiology, clinical spectrum, and current management options of this disorder. Imaging features of several cases are used to illustrate variations in the clinical presentation across the lifespan.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Brenner M, Johnson AB, et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet. 2001;27(1):117–20.

    Article  CAS  PubMed  Google Scholar 

  • Brenner M, Messing A. A new mutation in GFAP widens the spectrum of Alexander disease. Eur J Hum Genet. 2015;23(1):1–2.

    Article  CAS  PubMed  Google Scholar 

  • Graff-Radford J, Schwartz K, et al. Neuroimaging and clinical features in type II (late-onset) Alexander disease. Neurology. 2014;82(1):49–56.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hagemann TL, Connor JX, et al. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J Neurosci. 2006;26(43):11162–73.

    Article  CAS  PubMed  Google Scholar 

  • Li R, Johnson AB, et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol. 2005;57(3):310–26.

    Article  PubMed  Google Scholar 

  • Messing A, Brenner M, et al. Alexander disease. J Neurosci. 2012;32(15):5017–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Messing A, LaPash Daniels CM, et al. Strategies for treatment in Alexander disease. Neurotherapeutics. 2010;7(4):507–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pareyson D, Fancellu R, et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain. 2008;131(9):2321–31.

    Article  PubMed  Google Scholar 

  • Prust M, Wang J, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology. 2011;77(13):1287–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ramesh K, Sharma S, et al. Infantile-onset Alexander disease: a genetically proven case with mild clinical course in a 6-year-old Indian boy. J Child Neurol. 2013;28(3):396–8.

    Article  PubMed  Google Scholar 

  • Rodriguez D, Gauthier F, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet. 2001;69(5):1134–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • van der Knaap MS, Naidu S, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol. 2001;22(3):541–52.

    PubMed  Google Scholar 

  • van der Knaap MS, Ramesh V, et al. Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord. Neurology. 2006;66(4):494–8.

    Article  PubMed  Google Scholar 

  • van der Knaap MS, Salomons GS, et al. Unusual variants of Alexander’s disease. Ann Neurol. 2005;57(3):327–38.

    Article  PubMed  Google Scholar 

  • van der Voorn JP, Pouwels PJ, et al. Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter. Neuroradiology. 2009;51(10):669–75.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adeline Vanderver M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sabetrasekh, P., Alper, G., Vanderver, A. (2017). Alexander Disease Type II. In: Waubant, E., Lotze, T. (eds) Pediatric Demyelinating Diseases of the Central Nervous System and Their Mimics. Springer, Cham. https://doi.org/10.1007/978-3-319-61407-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61407-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61405-2

  • Online ISBN: 978-3-319-61407-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics